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Anetoderma (anetos, Greek for relaxed) of prema turity 
(AOP) is a rare dermatologic disorder characterized 
by atrophic skin lesions with sharp borders caused by 
localized loss of elastic fibers. While it seems that 
the most immature infants are at highest risk for 
this disease, the precise pathogenesis of the dis-
order remains to be defined. Because mortality rates 
of extremely low gestational age neonates (ELGANs) 
continue to decrease, we expect that AOP will 
in creasingly be seen and health care professionals 
caring for these patients should be familiar with this 
disorder. 
INTRODUCTION
3
CASE REPORT 1
4
This baby girl was born at 24 6/7 weeks of gestation to 
a G2/P2. The mother had been on metoprolol because 
of preexisting arterial hypertension. She was admit-
ted to the obstetric ward at 22 4/7 weeks of gesta-
tion due to worsening arterial hypertension. At 24 
0/7 weeks of gestation, magnesium sulphate in fusion 
for neu roprotection was started and corticoste roids 
were given for lung maturation. At 24 6/7 weeks of 
gestation, a Cesarean section was performed due to 
in trauterine growth restriction, pathologic Doppler 
signals in the umbilical vessels and progressive pre-
eclampsia. Apgar scores were 3, 2, and 5 at 1, 5, and 
10 minutes, respectively. Birth weight was 470 g (<P3), 
birth length 27.5 cm (< P3) and head circumference 
21 cm (P5 – 10).
The girl’s neonatal course was complicated by very 
sensitive skin with iatrogenic lesions on abdomen 
and chest (Fig. 1), ventilator dependence until day 
of life (DOL) 25, mild bronchopulmonary dysplasia 
(BPD), surgical closure of the patent ductus arteriosus, 
coagulase-negative Staphylococcus late-onset septi-
cemia (DOL 5), respiratory syncytial virus pneu monitis 
(DOL 34), and retinopathy of prematurity grade III 
with plus disease requiring bilateral laser therapy. 
No abnormalities were observed on cranial ultrasound. 
The baby was discharged home at 38 0/7 weeks of 
postmenstrual age (PMA) with a weight of 1860 g 
(<P3), length of 41.5 cm (<P3) and head circumference 
of 31 cm (<P3).
5Ten weeks after birth, a hypopigmented sharply 
bordered area on the right side of the trunk was 
observed for the first time. These lesions occurred 
in areas where transcutaneous pCO2 probes, ECG 
electrodes or disinfectants had been applied. The 
involved skin area increased in size over time, and 
the lesions became paler and atrophic. Fig. 2 A – C 
illustrates the evolution of the skin lesions over a 
6-year-period.
6Patient 1 (DOL 11; 26 4/7 weeks PMA): parchment-
like skin with ulcerations, dermal hemorrhages and 
desquamated lesions on abdomen and chest.
Fig. 1
A
Fig. 2
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Patient 1: evo lution of periumbilical AOP (A: 10th 
week of life, 36 5/7 weeks PMA; B: 7 months  
corrected age; C: age 5.5 years).
Patient 2: extensive skin changes consistent with AOP 
(A: 17 weeks corrected age; B: 11 months corrected 
age). 
Fig. 3
A B
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9CASE REPORT 2This pregnancy occurred after egg donation in a healthy 
G4/P2. Up to her emergency admission because of 
HELLP-syndrome, pregnancy had been uneventful. At 
25 3/7 weeks of gestation, a Cesarean section was 
performed before lung maturation could be com-
pleted. The male infant adapted well with Apgar scores 
of 3, 5, and 7 at 1, 5, and 10 minutes, respectively. His 
birth weight was 440 g (<P3), birth length 29.5 cm 
(P3 – 10) and head circumference 21.5 cm (P3 – 10). He 
was intubated in the delivery room and surfactant was 
administered.
Invasive and non-invasive respiratory support was 
necessary for 12 and 49 days, respectively. The neo-
natal course was complicated by mild BPD, a patent 
ductus arteriosus (closed with indomethacin), coagu-
lase-negative Staphylococcus late-onset septicemia, 
and Klebsiella pneumoniae septicemia with pneumo-
nia and meningitis. The infant was discharged home 
at 38 0/7 weeks PMA (DOL 89) with a weight of 2350 
g (<P3), a length of 44 cm (<P3) and a head circumfe-
rence of 33 cm (P10).
In the first days of life, his skin was noted to be very 
fragile and many erosive lesions appeared. At 36 0/7 
weeks PMA, a pale, sharply bordered and atrophic 
area on the abdomen was noted for the first time. 
Fig. 3 A, B illustrate the evolution of the skin lesions 
during the first year of life. 
CASE REPORT 3
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This baby girl was born at 24 2/7 weeks of gestation 
to a G2/P1. The mother had been admitted two weeks 
earlier because of preterm labor and vaginal bleeding. 
At 23 2/7 weeks of gestation, antenatal corticoste-
roids for lung maturation were administered following 
rupture of membranes. Because of persistent contrac-
tions and fetal bradycardia, a Cesarean section was 
performed at 24 2/7 weeks. Partial placental abrup-
tion was confirmed intraoperatively. Birth weight was 
700 g (P50 – 75), birth length 31 cm (P25 – 50) and 
head circumference 21.5 cm (P10 – 25). The infant was 
intubated in the delivery room and admitted to the 
NICU after surfactant administration.
The neonatal course was characterized by prolonged 
non-invasive positive pressure ventilation, mild BPD, 
and two episodes of late-onset septicemia possibly 
due to severe iatrogenic skin lesions (Fig. 4). The girl 
was discharged home at 37 2/7 weeks PMA with 
a weight of 2980 g (P10 – 25), a length of 46.5 cm 
(P3 – 10) and a head circumference of 34.5 cm (P50 – 75). 
Fig. 5A, B document the evolution of the skin lesions 
over the first year of life.
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Fig. 4
Patient 3 (DOL 4; 24 5/7 weeks PMA): ): intense 
inflammatory reaction of the skin on chest and upper 
extremities (left arm: blood pressure device; right 
arm: ECG electrode), and abdomen (following  
disinfection prior to insertion of umbilical catheters).
Patient 3 (A: 12th week of life; 36 2/7 weeks PMA;  
B: 1 year corrected age): sharply bordered translucent 
skin areas on the chest and abdomen.
Fig. 5
A B
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Fig. 6
Patient 4 (16th week corrected age): periumbilical 
hypopigmented atrophic skin areas. 
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This male infant was born at 24 5/7 weeks of gesta-
tion to a G2/P1 who had been admitted three days 
earlier because of preterm labor. Antenatal corticoste-
roids for lung maturation were given on admission. 
When signs of chorioamnionitis developed, a Cesarean 
section was performed. The infant was intubated in 
the delivery room and surfactant was administered. 
Birth weight was 870 g (P50 – 75), birth length was 
34.5 cm (P50 – 75) and head circumference was 
23.5 cm (P25 – 50).
The boy was extubated on DOL 11 and put on non-
invasive respiratory support for another 35 days. Apart 
from conservatively treated meconium plug syndrome 
and mild BPD, no severe morbidities were observed. 
He was discharged home at 38 3/7 weeks PMA with a 
weight of 2680 g (P5 – 10), a length of 47 cm (P3 – 10) 
and a head circumference of 33.5 cm (P10 – 25).
In this patient, periumbilical atrophic and hypo-
pigmented skin lesion were first observed at 37 1/7 
weeks PMA, shortly before discharge form the NICU 
(Fig. 6). 
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CASE REPORT 4
Typical localization of anteo-
derma of prematurity (AOP)
 AOP distribution pattern  
 described by Prizant el al. (5)
 Case report 1
 Case report 2
 Case report 3
 Case report 4
Fig. 7
Distribution pattern of AOP in ELGANs described in 
the literature (5) and in the four cases presented in 
this report.
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DISCUSSION In 1891, Schwenninger and Buzzi were the first to 
use the term «anetoderma» to describe atrophic skin 
lesions in adult patients (1). The term referred to sharply 
bordered and depigmented areas with decreased skin 
thickness. Frequently, the affected skin runs through 
a phase of inflammation months before achieving this 
final stage. Herniation of the structure underlying the 
skin lesion has been reported. The histopathologic 
examination of the atrophic skin areas demonstrates 
isolated perivascular lymphocytic infiltrations in the 
dermis with a loss of elastic fibers (2).
Anetoderma can occur as a primary, idiopathic 
dis order (historically subclassified into two types, the 
Jadassohn-Pellizzari type and the Schweninger-Buzzi 
type, depending, respectively, on the presence or 
absence of prior inflammation at the site of the lesion). 
Secondary anetoderma, on the other hand, has been 
des cribed in patients with associated diseases, inclu-
ding autoimmune, infectious, and inflammatory 
conditions, benign and malignant tumors, as well as 
associated with drugs (i.e., drug-induced) (3).
Following an initial description of permanent skin 
changes related to transcutaneous oxygen monitoring 
by Golden in 1981 (4), Prizant et al. were the first to 
use the term anetoderma to describe atrophic patches 
in extremely preterm infants (5). They speculated that 
anetoderma of prematurity (AOP) was due to extreme 
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prematurity and possibly iatrogenic in origin. Additio-
nal reports of AOP have since been published (Table 1) 
(3 – 11). The majority of patients with AOP are extre-
mely preterm infants. 
The diagnosis of AOP is primarily based on clinical 
examination and evaluation of the patient’s clinical 
course; histopathology of a skin biopsy is usually not 
necessary. Over the years, the affected atrophic skin 
areas grow together with the child, thus the percen-
tage of affected skin remains constant. The lesions 
have no specific localization, although trunk and 
extremities seem to be the most frequently affected 
regions. 
While the pathogenesis of AOP is poorly understood, 
several promotive conditions have been described, 
favoring the hypothesis of a multifactorial mechanism 
(Table 2). These conditions can be of physical, toxic 
or immunologic nature, and are associated with the 
development of a local dermal inflammatory reaction, 
responsible for damaging dermal tissue with consecu-
tive loss of elastic fibers.
In the very premature infant, distension of the skin 
by removing adhesive tape or ECG electrodes can 
harm its elastic fibers (3, 5, 8, 11). Continuous com-
pression of the skin through prolonged prone position 
on ECG electrodes or other devices may cause local 
hypoperfusion with consecutive damage to the der-
Table 1. Published cases of iatrogenic anetoderma in 
preterm infants (3 – 11).
Reference Patients Comment
Authors Year N GA range BW range
Golden SM (4) 1981 2 24 – 30 
weeks
620 – 1640 g Hyperpigmented skin craters 
following prolonged tcpO2 
monitoring
Prizant TL et al. (5) 1996 9 24 – 29 
weeks
595 – 1530 g Affected areas corresponded 
with placement of monitoring 
leads or adhesive tape; on 
biopsy reduction or absence of 
elastic fibers noted in 4 of 5 
patients
Todd DJ (6) 1997 1 32 weeks 795 g Birth weight (and skin thick-
ness) may be more important 
than gestational age
Zellman GL, et al. 
(7)
1997 2 25 weeks 680 – 780 g Congenital anetoderma in fra-
ternal twins
Colditz PB, et al. (8) 1999 2 27 weeks 520 – 630 g Lesions located on forehead  
following ECG lead place-
ment for electrical impedance 
monitoring of cerebral blood 
volume; growth restricted 
infants may be particularly 
vulnerable
Ben-Amitai, et al. 
(9)
2008 2 26 weeks 1050 – 1200 g Anetoderma in premature 
identical twins
Wain EM, et al. (10) 2008 1 24 weeks 640 g Congenital anetoderma in sur-
viving twin following feticide 
of co-twin because of multiple 
severe congenital anomalies
Goujon E, et al. (11) 2010 11 25 – 30 
weeks
725 – 1250 g Anetoderma of prematurity 
likely results from unnoticed 
minor iatrogenic trauma (ECG 
leads, adhesive tape)
Maffeis L, et al. (3) 2014 1 24 weeks 470 g Numerous, localized, round-
flat, and atrophic patches 
of skin on upper chest first 
noticed between 4th and 5th 
month of age while in the 
NICU
Glauser D, et al. 2016 4 24 – 25 
weeks
440 – 870 g Case series presented as COTM 
September 2016
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Table 2. Possible predisposing conditions for the 
development of AOP.
Mechanism Description
Physical stress Mechanical distention of the skin 
(removal of adhesive tape or ECG 
electrodes)
Mechanical pressure (ischemia by 
pressure of body weight in prone 
position) 
Heat stress (transcutaneous pO2/
pCO2-device at 42 – 44°C)
Toxic effect Gel from electrodes or disinfectant 
solutions
Immunologic mechanism Allergic reactions (components of 
electrodes or adhesive tapes)
Maternal passive immunity
19
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mal tissue. Cutaneous heat stress by transcutaneous 
pO2/pCO2-devices (heated up to 44°C) will also harm the 
elastic fibers (4). Toxic ingredients which are in contact 
with the immature skin, for example gel electrodes or 
disinfectant solutions, could also play a role. Finally, 
immunologic factors have also been implicated in the 
pathogensis of AOP. 
Our patients share several features that might have 
played an important role in the pathogenesis of AOP. 
They were all ELGANs requiring long-term NICU moni-
toring. Following admission to our NICU and after 
periumbilical disinfection with Octenisept®, umbilical 
catheters were inserted in all four cases. Octenisept® is 
a colorless disinfectant for skin and mucous membra-
nes. The active ingredient is octenidine dihydrochlo-
ride and phenoxyenthanol is added as a preserving 
agent. The minimum exposure time of Octenisept® for 
skin disinfection is one minute. In animal experiments, 
no systemic absorption was observed following oral 
or topical administration. No cutaneous side effects 
of Octenisept® have been reported, and, according 
to Swissmedic (12), it may be used in babies and 
premature infants (without indicating any gestational 
age limit below which it should not be used). Accor-
ding to our local protocol, the infants were monitored 
with ECG electrodes, a transcutaneous pO2/pCO2 sen-
sor (heated at 42°C and placed on the trunk and/or 
legs) and an oximetry sensor placed on the extremities. 
No additional monitoring devices were attached to 
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the infants’ skin. Dermal lesions were mainly localized 
on the trunk, in areas where monitoring devices are 
often applied, and in the periumbilical region where 
skin disinfection is used before umbilical catheters are 
placed (Fig. 7). 
As long as the pathogenesis of AOP is unknown, the-
rapeutic options remain symptomatic and prevention 
of skin damage appears to be essential. Continu-
ous monitoring of vital functions of extremely pre-
mature infants in the NICU is unavoidable and skin 
disinfection is required for many interventions, such 
as blood sampling or the insertion of intravascular 
cannulas. Safety precautions for skin care are of 
utmost importance and should include safe techniques 
for removal of monitoring devices and ad hesive tape. 
Furthermore, comfortable positioning of the infant 
to avoid skin compression by the devices is impor-
tant. Surgical correction of AOP lesions is sometimes 
required because of herniation of underlying struc-
tures or because of aesthetic problems (3). 
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